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A balanced colonisation by endogenous vaginal microflora of the 
lower female genital tract consists of predominantly Lactobacillus 
species,1 co-existing with vaginal anaerobes and aerobes such 
as Streptococcus agalactiae (e.g. group B streptococci)2 and the 
Bacteroides family.3 Disturbing this microbial milieu results in 
overgrowth of bacterial vaginosis-related organisms which 
are associated with a 3 - 6 times greater risk of postpartum 
endometritis.4,5 However, the role of endogenous lower genital tract 
pathogens, especially bacterial vaginosis organisms, and their impact 
on postpartum infectious morbidity, is controversial.6,7 Other vaginal 
organisms associated with postpartum infectious morbidity include 
Ureaplasma urealyticum, group B streptococcus (GBS) and other 
sexually transmitted infections (STIs) such as Trichomonas vaginalis, 
Neisseria gonorrhoeae and Chlamydia trachomatis. Case detection 
and treatment of the latter STIs is often technically difficult and 
expensive. Furthermore, the prevalence of genital tract infections 
is probably higher among HIV-positive women because of their 
associated immunosuppression. Studies have shown perturbations 
in the vaginal flora of HIV-infected women, with approximately 
20% of HIV-infected women having Lactobacillus-dominant vaginal 
flora.8,9  Cu-Uvin et al. found no difference in the prevalence rates of Corresponding author: J Moodley (tombe@ukzn.ac.za)
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Objectives. To determine the prevalence of vaginal pathogens 
during pregnancy and their impact on postpartum infectious 
morbidity among antiretroviral-naïve HIV-infected, and HIV-
uninfected, women.
Methods. Vaginal swabs were obtained during early labour 
by speculum examination prior to digital vaginal examination, 
and sent for microscopy and culture. Women were assessed for 
infectious complications within 24 - 72 hours of delivery, and up to 
2 weeks postpartum.
Results. Laboratory results were available for 801 women who 
delivered vaginally (418 HIV infected and 383 uninfected). The 
baseline characteristics of the two groups were comparable, and 
the median CD4 count for HIV-infected women (N=391) was 
416/µl. Fifty-five per cent (54.8%) of women had positive cultures 
(439/801), more among those who were HIV infected than 
uninfected (60% v. 49.1%, p=0.002). Women with positive cultures 
had slightly higher rates of infectious morbidity than those without 
(20.5% v. 15.2%, p=0.052). Trichomonas vaginalis and group B 
streptococci were significantly associated with sepsis (p=0.023 and 
<0.001, respectively), whereas the presence of Candida species 
seemed to be protective (relative risk 0.69, p=0.014).
Conclusion. The study shows that a high proportion of pregnant 
women have pathogenic organisms in the lower genital tract 
that are associated with development of postpartum infectious 
morbidity.
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lower genital tract infections among HIV-infected women compared 
with HIV-uninfected women.10 These conflicting findings led us to 
determine the prevalence of lower genital tract infections during 
pregnancy and their impact on postpartum infectious morbidity 
among HIV-infected and uninfected women.
Methods
Study population
Our study was nested within a prospective trial of 1 404 women 
(716 HIV positive compared with 688 HIV negative) over a 2-year 
period.11,12 Women of 18 years and older, and who were at 36 weeks’ 
gestation and greater, in whom vaginal delivery was anticipated, were 
enrolled after obtaining consent. In addition to standard antenatal 
tests, pre- and post-test HIV counselling and HIV rapid testing were 
offered to all the women. CD4 lymphocyte counts were performed 
in the HIV-infected women. Vaginal swab specimens were obtained 
during early labour by speculum examination prior to digital vaginal 
examination. Since the parent study involved randomising HIV-
infected women to receive either a stat dose of cefoxitin or placebo, 
the specimens were taken before the administration of the study 
drug. The vaginal swab specimens were rolled onto a glass slide for 
the determination of a bacterial vaginosis (BV) score using Nugent’s 
criteria,13 and then transported in Ames medium (for detection of 
Gram-negative and positive organisms) and Diamond’s medium (for 
detection of trichomoniasis). In the laboratory, the swabs were also 
inoculated on cefoxitin CLED plates, bacitracin choc plate and laked 
blood cefoxitin, for the detection of any significant isolates, and an 
AMS plate was inoculated to detect the presence of any antimicrobial 
substances. Significant isolates were identified, and susceptibilities 
were determined.  Screening tests for syphilis (rapid plasma reagin) 
were also performed, and presence or absence of vulvo-vaginal warts 
was noted during speculum examination. Swab specimens for N. 
gonorrhoeae and Chlamydia species were not taken.
Demographic details and obstetric information were obtained, 
including: the number of vaginal examinations before and after the 
rupture of membranes, duration of ruptured membranes, and mode 
of delivery. All deliveries were conducted by professional midwives 
or doctors. Women were assessed for infectious complications within 
24 - 72 hours of delivery, at 1 week (range 6 - 10 days), 2 weeks (range 
11 - 17 days) and 6 weeks (40 - 49 days) postpartum. Infection occurring 
at any time point up to 2 weeks was recorded as a positive result. Only 
participants who had all microbiological laboratory results available were 
analysed.
Statistical analysis
Data were captured on Epi-Info 6 and imported for analyses into SPSS 
version 15.0 (SPSS Inc., Chicago, Ill.). A p-value <0.05 was considered 
statistically significant. Pearson’s chi-square analysis was used to 
compare categorical variables between groups. Quantitative variables 
were compared between treatment groups using independent t-tests 
or non-parametric Mann-Whitney tests as appropriate. Generalised 
linear models estimated crude and adjusted relative risks. The 
dependent variable was modelled as binary with a log link to estimate 
relative risks. For multivariable analysis, the independent variables 
were chosen as those which were statistically significant at the 90% 
level of confidence on crude analysis. They were entered as main 
effects. Relative risks (RR) and 95% confidence intervals (CI) were 
reported.  Since HIV status and mode of delivery were possible 
confounders, these were entered into the model, and adjusted relative 
risks were calculated.
Results
Laboratory results were available for 801 (418 HIV infected and 
383 uninfected) of the 885 who had vaginal deliveries (including 
episiotomy and assisted deliveries). Baseline characteristics of the 
two groups were comparable, with no statistical differences in mean 
age, parity and body weight. The median CD4 count for HIV-infected 
women (N=391) was 416/µl (range 24 - 1 393), with 49/391 (12.5%) 
having CD counts <200/µl.
Overall, 439/801 (54.8%) had positive cultures, which was 
significantly more among HIV-infected women (251/418 (60%)) 
than HIV uninfected (188/383 (49.1%), p=0.002). T. vaginalis, BV 
and Candida species were significantly more prevalent among HIV-
infected than uninfected women, as was vulvo-vaginal warts (Table 
I). Of these organisms, only T. vaginalis was significantly associated 
with presence of vaginal discharge on enquiry (p<0.001) (the p-value 
was 0.391 for BV and 0.080 for Candida species). Other organisms 
that were cultured included streptococci (groups B and F), as well 
as Gram-negative bacilli, none of which was significantly different 
among the HIV-infected and uninfected groups. Syphilis serology 
Table I. Vaginal pathogens according to HIV status
HIV status
       Positive        Negative
Count % Count % RR (95% CI) p-value
Positive cultures 251 60.0 188 49.1 1.22 (1.08 - 1.39) 0.002
Bacterial vaginosis 161 38.5 109 28.5 1.35 (1.11 - 1.65) 0.003
T. vaginalis 56 13.4 30 7.8 1.29 (1.08 - 1.53) 0.011
Group B streptococci 10 2.4 10 2.6 0.92 (0.39 - 2.18) 0.843
Candida 164 39.2 115 30 1.31 (1.08 - 1.59) 0.006
Group F streptococci 6 1.4 4 1.0 1.37 (0.39 - 4.83) 0.619
Gram-negative bacilli 104 24.9 91 23.8 1.05 (0.82 - 1.34) 0.712
Syphilis serology 26 6.5 14 3.7 1.74 (0.92 - 3.28) 0.082
Vulvo-vaginal warts 14 3.3 4 1.0 3.21 (1.06 - 9.66) 0.028
RR = relative risk for presence of pathogens in HIV-positive compared with HIV-negative women. 
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reactivity was also slightly more among HIV-infected women than 
among those who were uninfected (p=0.082).
Association between vaginal organisms 
and development of postpartum infectious 
complications
The overall puerperal sepsis rate in this cohort was 18.1% (145/801) 
over the 2 weeks of follow-up. Women with positive cultures had 
higher rates of infectious morbidity than those without (90/439 
(20.5%) v. 55/362 (15.2%), p=0.052).
HIV status was not associated with development of sepsis (p=0.391) 
in crude or multivariable analysis and was therefore omitted from 
the multivariable model. Mode of delivery, Candida, T. vaginalis, 
Gram-negative bacilli and group B streptococci were added to the 
multivariable model as independent variables. After adjustment for 
confounding effects, assisted vaginal delivery or episiotomy posed a 
significantly higher risk for sepsis than non-assisted normal vaginal 
delivery (NVD) (p=0.001). The presence of Candida species seemed 
to be protective (RR 0.66, 95% CI 0.47 - 0.92) (Table II), while T. 
vaginalis, Gram-negative bacilli and group B streptococci were all 
significant risk factors for sepsis.
Discussion
In this cohort, more than 50% of women had culture-positive 
pathogenic organisms detected during early labour, which represents 
a very high rate of microbial pathogens in the lower genital tract 
of pregnant women who were asymptomatic, with the exception 
of a possible vaginal discharge. However, similar rates have been 
reported.14,15 In a similar population, one or more STIs was found to 
be present in 16.5% of asymptomatic antenatal patients.15 Though not 
statistically significant, postpartum infectious morbidity was higher 
in women with positive cultures (p=0.052). Furthermore, in our 
study, positive cultures were significantly higher among HIV-infected 
(60%) than HIV-uninfected women (49.1%, p=0.002). The difference 
according to HIV status was expected and is in keeping with other 
reports of increased rates of lower genital tract pathogens among 
HIV-infected women.16
A higher incidence of infectious morbidity among HIV-infected 
women was expected in view of their higher rate of positive 
cultures. The lack of influence of HIV status on the development of 
postpartum infectious morbidity in our study has also been noted in 
other reports;11,12 this is probably because  most HIV-infected women 
in our study were immunocompetent, with mean CD4 counts >350.
The most common organisms detected in our study were 
associated with BV, with rates in keeping with other sub-Saharan 
Africa rates of up to 50%.8,17,18 Although organisms associated with 
BV were the most prevalent, there was surprisingly no association 
between presence of BV and postpartum infectious morbidity. 
The vast literature showing an association of BV with pregnancy 
complications has mainly focused on preterm labour and delivery, 
Table II. Association between development of infectious morbidity and presence of organisms
Parameter      Infectious morbidity: N (%)        p-value Crude RR (95% CI)          Adjusted RR* (95% CI)      p-value
HIV
Positive      71 (17.0)         0.391  1.14 (0.85 - 1.53)
Negative     74 (19.3)
Mode of delivery 
Assisted/episiotomy    88 (23.3)         <0.001 1.74 (1.28 - 2.35)          1.71 (1.26 - 2.31)      0.001
Normal delivery     57 (13.4)
Syphilis 
Positive      6 (15)           0.568  0.81 (0.38 - 1.71)
Negative     137 (18.6)
Vaginal warts
Positive      4 (22.2)         0.550  1.23 (0.51 - 2.97)
Negative     141 (18)
Candida
Positive      39 (14)         0.027  0.69 (0.49 - 0.96)           0.66 (0.47 - 0.92)      0.014
Negative     106 (20.3)
Bacterial vaginosis
Positive      47 (17.4)         0.716  0.94 (0.69 - 1.29)
Negative     98 (18.5)
Group F strep.
Positive      3 (30)          0.399  1.67 (0.64 - 4.36)
Negative     142 (18)
T. vaginalis
Positive      26 (30.2)         0.002  1.82 (1.27 - 2.61)          1.49 (1.06 - 2.11)      0.023
Negative     119 (16.6)
Gram-negative bacillli 
Positive      44 (22.6)         0.063  1.35 (0.99 - 1.86)          1.48 (1.09 - 2.01)      0.013
Negative     101 (16.7)
Group B strep.
Positive      11 (55)         <0.001 3.21 (2.10 - 4.90)          2.62 (1.76 - 3.91)      <0.001
Negative     134 (17.2)
*Adjusted for mode of delivery, Candida, T. vaginalis, Gram-negative bacilli, and group B Streptococci.
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and subsequently postpartum endometritis.19 We postulate that the 
postpartum endometritis in those studies is a continuation of the 
preceding inflammatory process that led to miscarriage or preterm 
labour, and asymptomatic women who proceed to term are less likely 
to experience BV-associated complications in the postpartum period. 
This observation could explain the lack of association between the 
presence of BV and postpartum infectious morbidity in our cohort of 
otherwise asymptomatic women, recruited at ≥ 36 weeks’ gestation.
We showed a significant association of postpartum infectious 
morbidity and presence of T. vaginalis. This organism colonises the 
lower genital tract, and is therefore not expected to be associated 
with upper genital disease (above the level of the internal cervical 
os). T. vaginalis has been documented in the upper genitalia and is 
associated with pelvic inflammatory disease in those who are HIV 
infected,20 but not among those without HIV infection. Although 
small numbers were T. vaginalis positive, our study also found a 
significant association between T. vaginalis and postpartum infections 
in the whole cohort (p=0.010), and particularly among HIV-infected 
women (relative risk (RR) 3.36, p=0.009) rather than HIV-uninfected 
women (RR 1.29, p=0.599). This association between HIV and T. 
vaginalis-associated morbidity may suggest an altered host-microbe 
relationship, resulting in an apparent increased risk of upper genital 
tract infection.20 Since the parent study involved randomising HIV-
infected women to a single dose of 2 grams of cefoxitin and placebo, 
cefoxitin administration was found to significantly reduce the 
development of infectious morbidity in women who had T. vaginalis 
(RR 0.18, 95% confidence interval 0.03 - 1.22, p=0.024). Cefoxitin has 
little effect on anaerobes such as T. vaginalis, and it therefore raises the 
possibility that its effect is more on the ‘secondary invaders’ that cause 
infection in mucosa that is already compromised by the presence of 
T. vaginalis. This relationship is well known in the development of 
pelvic inflammatory disease in non-pregnant women.21
As expected, the presence of GBS was strongly associated with 
development of postpartum infections. However, the prevalence 
rate of GBS in our study was much lower than the 15% prevalence 
rate reported previously from the same institution.22 This may be 
due to swabs only being taken from the cervico-vaginal area in this 
study, whereas Naidoo et al. noted that a combination of vaginal and 
introital swabs increased the yield for GBS by 25%.22
Candida species were present in at least 30% of our cohort; 
however, most women were asymptomatic. A surprising finding in 
our study was that the presence of Candida organisms protected 
against the development of postpartum infectious morbidity, which 
persisted even after controlling for other variables. Further studies are 
needed to confirm this.
In conclusion, HIV-positive women did not have an increased 
risk of postpartum infectious morbidity despite higher rates of 
pathogens in the lower genital tract, a finding which may be due to 
the reasonably intact immune system of the study cohort. However, 
the presence of T. vaginalis, Gram-negative bacilli and group B 
streptococci was associated with a significantly increased risk of 
postpartum morbidity, irrespective of HIV status.
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